tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Bright Minds Biosciences Inc. (DRUG)
:DRUG
US Market
DRUG
Bright Minds Biosciences
Overview
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Bright Minds Biosciences (DRUG) Stock News & Sentiment

Compare
215 Followers
Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential
Premium
Ratings
Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential
3d ago
DRUG
Bright Minds Biosciences Shows Financial Improvement in Latest Report
Premium
Company Announcements
Bright Minds Biosciences Shows Financial Improvement in Latest Report
8d ago
6K
DRUG
Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics
Premium
Company Announcements
Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics
2M ago
DRUG
Bright Minds Biosciences (DRUG) Finishes the Year with Phenomenal Share Price Increase
Premium
Market News
Bright Minds Biosciences (DRUG) Finishes the Year with Phenomenal Share Price Increase
2M ago
AIFF
DRUG
Bright Minds Biosciences to Present Novel Epilepsy Data
Premium
Company Announcements
Bright Minds Biosciences to Present Novel Epilepsy Data
3M ago
DRUG
Bright Minds Biosciences Secures $35 Million Investment
Premium
Company Announcements
Bright Minds Biosciences Secures $35 Million Investment
4M ago
6K
DRUG
Bright Minds Biosciences (DRUG) Partners with Firefly Neuroscience, Resulting in Stock Surge
Premium
Market News
Bright Minds Biosciences (DRUG) Partners with Firefly Neuroscience, Resulting in Stock Surge
4M ago
AIFF
DRUG
More DRUG News >

DRUG News on the Web

Biotechs on the Brink: 2 Stocks With Huge Potential
MarketBeat
Neutral
Bright Minds Biosciences (DRUG) Finishes the Year with Phenomenal Share Price Increase
TipRanks News
Neutral
Bright Minds Biosciences to Present Novel Epilepsy Data
TipRanks News
Neutral
Bright Minds and Firefly Neuroscience Renew Collaboration
TipRanks News
Neutral
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
Yahoo Finance
Neutral
Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
Yahoo Finance
Neutral
Bright Minds’ BMB-201 Shows Promise in Pain Relief
TipRanks News
Neutral
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DRUG
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DRUG’s Media Buzz Sentiment?
Currently, no data Available
What is DRUG’s weekly average amount of articles?
Currently, no data Available
What is DRUG’s News Sentiment?
50% of articles about DRUG were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    SHGSingular Health Group Ltd
    RCUSArcus Biosciences
    HCMHUTCHMED
    PENPenumbra
    AMNAMN Healthcare Services
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing